N-[(2-Chlorophenyl)methyl]-4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamide

Catalog No. :
ACBIKE012
CAS No. :
339025-44-4
Molecular Formula :
C21H16ClF3N2O2
Molecular Weight :
420.82

IUPAC Name:N-(2-chlorobenzyl)-4-((2-oxo-5-(trifluoromethyl)pyridin-1(2H)-yl)methyl)benzamide

N-[(2-Chlorophenyl)methyl]-4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[(2-Chlorophenyl)methyl]-4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamide
IUPAC NameN-(2-chlorobenzyl)-4-((2-oxo-5-(trifluoromethyl)pyridin-1(2H)-yl)methyl)benzamide
Molecular FormulaC21H16ClF3N2O2
Molecular Weight420.82
SMILESO=C(NCC1=CC=CC=C1Cl)C2=CC=C(CN3C=C(C(F)(F)F)C=CC3=O)C=C2
InChI KeyVBYZSRYTFUJRHY-UHFFFAOYSA-N
SynonymN-(2-CHLOROBENZYL)-4-([2-OXO-5-(TRIFLUOROMETHYL)-1(2H)-PYRIDINYL]METHYL)BENZENECARBOXAMIDE;N-[(2-chlorophenyl)methyl]-4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamide;Benzamide, N-[(2-chlorophenyl)methyl]-4-[[2-oxo-5-(trifluoromethyl)-1(2H)-pyridinyl]methyl]-
CAS No.339025-44-4

Synthetic Route by SureRoute

1. ACBIKE012 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJUSP486 route compound structure diagram
    ACJUSP48622680-44-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBIKE012 route product structure diagram
    ACBIKE012339025-44-4
Inquiry

2. ACBIKE012 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJUSP486 route compound structure diagram
    ACJUSP48622680-44-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBIKE012 route product structure diagram
    ACBIKE012339025-44-4
Inquiry

Comments (0)